Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Osteoarthritis.

Mary B Goldring1, Steven R Goldring

  • 1Laboratory for Cartilage Biology, Research Division, The Hospital for Special Surgery, Weill College of Medicine of Cornell University, New York 10021, USA. goldringm@hss.edu

Journal of Cellular Physiology
|September 6, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacokinetic and biodistribution (PK/BD) study of ProGel-Dex, a thermoresponsive dexamethasone prodrug for sustained joint pain relief in a mouse model of osteoarthritis.

Nanomedicine : nanotechnology, biology, and medicine·2025
Same author

Joint damage is more severe following a single bout than multiple bouts of high magnitude loading in mice.

Osteoarthritis and cartilage·2025
Same author

Intradermal Injection of a Thermoresponsive Polymeric Dexamethasone Prodrug (ProGel-Dex) Ameliorate Dermatitis in an Imiquimod (IMQ)-Induced Psoriasis-like Mouse Model.

Molecular pharmaceutics·2024
Same author

Identification of formulation parameters that affect the analgesic efficacy of ProGel-Dex - A thermoresponsive polymeric dexamethasone prodrug for chronic arthritis pain relief.

Nanomedicine : nanotechnology, biology, and medicine·2024
Same author

PTH treatment before cyclic joint loading improves cartilage health and attenuates load-induced osteoarthritis development in mice.

Science advances·2024
Same author

Thermoresponsive Polymeric Hydromorphone Prodrug Provides Sustained Local Analgesia without Apparent Adverse Effects.

Molecular pharmaceutics·2024

Osteoarthritis (OA) involves cartilage degeneration and bone changes, driven by aging and genetics. Current treatments are insufficient, highlighting the need for new therapies targeting chondrocyte function and tissue regeneration.

Area of Science:

  • Orthopedics and Rheumatology
  • Cell Biology
  • Biomedical Engineering

Background:

  • Osteoarthritis (OA) is a degenerative joint disease affecting articular cartilage, synovium, and bone.
  • Pathogenesis involves mechanical factors, aging, genetics, and inflammatory mediators produced by chondrocytes.
  • Current treatments for OA pain are inadequate, and no structure-modifying therapies are proven.

Purpose of the Study:

  • To review current research on osteoarthritis pathogenesis mechanisms.
  • To identify effective therapeutic strategies, focusing on chondrocyte function and cell interactions.
  • To explore advancements in cartilage tissue engineering and gene therapy for OA.

Main Methods:

  • Literature review of current research on osteoarthritis mechanisms and therapies.

Related Experiment Videos

  • Focus on studies investigating chondrocyte behavior and interactions with joint tissues.
  • Analysis of animal models for their relevance to human osteoarthritis.

    • Main Results:

    • Chondrocytes are central to OA pathogenesis, attempting to regenerate cartilage with limited success.
    • Interactions between chondrocytes, synovium, and subchondral bone significantly contribute to disease progression.
    • Existing animal models do not fully replicate human osteoarthritis complexity.

    Conclusions:

    • Understanding chondrocyte dysfunction and tissue interactions is crucial for developing effective OA therapies.
    • Cartilage tissue engineering and gene therapy show promise but require further investigation.
    • Novel therapeutic strategies are needed to address the limitations of current OA treatments.